onabotulinumtoxinA

CHEBI:CHEBI_750497

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
onabotulinumtoxinA
rxcui
1726313
product_type
HUMAN PRESCRIPTION DRUG
labeler_name
Allergan, Inc.
manufacturer_name
Allergan, Inc.
listing_expiration_date
20251231
route
INTRADERMAL
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
pharm_class_pe
Neuromuscular Blockade [PE]
pharm_class
Acetylcholine Release Inhibitors [MoA]
marketing_category
BLA
active_ingredient_name
BOTULINUM TOXIN TYPE A
active_ingredient_strength
200 [USP'U]/1
unii
E211KPY694
nui
N0000175770
pharm_class_epc
Neuromuscular Blocker [EPC]
pharm_class_moa
Acetylcholine Release Inhibitors [MoA]
marketing_start_date
20080715
package_marketing_start_date
20080715
brand_name
BOTOX
brand_name_base
BOTOX
product_ndc
0023-3921
application_number
BLA103000
spl_id
134b1e91-ae75-41db-a8d1-fe52c1ec6c45
package_ndc
0023-3921-03
package_description
1 VIAL in 1 CARTON (0023-3921-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
spl_set_id
33d066a9-34ff-4a1a-b38b-d10983df3300
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class